OpenAlex
PricingAboutJobs
Log inGet started
Work

A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification

HTML PDF

Year: 2017
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
DOI: 10.1093/annonc/mdx107
Authors: E. Van Cutsem, Y.-J. Bang, W. Mansoor, R.D. Petty, Y. Chao, D. Cunningham, D.R. Ferry, N.R. Smith, P. Frewer, J. Ratnayake, P.K. Stockman, E. Kilgour, D. Landers
Institutions: KU Leuven, Seoul National University, The Christie NHS Foundation Trust, University of Dundee, Taipei Veterans General Hospital, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, New Cross Hospital, AstraZeneca (United Kingdom)
Language: English

Topic: Gastric Cancer Management and Outcomes
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: AZD4547, FGFR tyrosine kinase inhibitors, paclitaxel, advanced gastric adenocarcinoma, second-line therapy, progression-free survival, intratumoral heterogeneity, biomarker concordance, drug safety, fluorescence in situ hybridization, oral tyrosine kinase inhibitor
SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, AstraZeneca
OpenAlex ID: W2620739030
FWCI: 9.817
Cites: 26
Cited by: 201
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security